These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22277901)
1. Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer. Kuo WH; Lin PH; Huang AC; Chien YH; Liu TP; Lu YS; Bai LY; Sargeant AM; Lin CH; Cheng AL; Hsieh FJ; Hwu WL; Chang KJ J Hum Genet; 2012 Feb; 57(2):130-8. PubMed ID: 22277901 [TBL] [Abstract][Full Text] [Related]
2. BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer. Cao W; Wang X; Gao Y; Yang H; Li JC Anat Rec (Hoboken); 2013 Feb; 296(2):273-8. PubMed ID: 23175448 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Zhang J; Pei R; Pang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y Breast Cancer Res Treat; 2012 Apr; 132(2):421-8. PubMed ID: 21614564 [TBL] [Abstract][Full Text] [Related]
4. Screening of BRCA1/2 Mutations Using Direct Sequencing in Indonesian Familial Breast Cancer Cases. Anwar SL; Haryono SJ; Aryandono T; Datasena IG Asian Pac J Cancer Prev; 2016; 17(4):1987-91. PubMed ID: 27221885 [TBL] [Abstract][Full Text] [Related]
5. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women. Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188 [TBL] [Abstract][Full Text] [Related]
6. Identification of Recurrent Variants in Jiang Y; Tian T; Yu C; Zhou W; Yang J; Wang Y; Wen Y; Chen J; Dai J; Jin G; Ma H; Shen H; Hu Z Biomed Res Int; 2020; 2020():6739823. PubMed ID: 32879886 [No Abstract] [Full Text] [Related]
7. Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Zhang J; Sun J; Chen J; Yao L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y Breast Cancer Res Treat; 2016 Aug; 158(3):455-62. PubMed ID: 27393621 [TBL] [Abstract][Full Text] [Related]
8. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. FitzGerald MG; MacDonald DJ; Krainer M; Hoover I; O'Neil E; Unsal H; Silva-Arrieto S; Finkelstein DM; Beer-Romero P; Englert C; Sgroi DC; Smith BL; Younger JW; Garber JE; Duda RB; Mayzel KA; Isselbacher KJ; Friend SH; Haber DA N Engl J Med; 1996 Jan; 334(3):143-9. PubMed ID: 8531968 [TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation. Seong MW; Cho S; Noh DY; Han W; Kim SW; Park CM; Park HW; Kim SY; Kim JY; Park SS Clin Genet; 2009 Aug; 76(2):152-60. PubMed ID: 19656164 [TBL] [Abstract][Full Text] [Related]
11. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance. Caligo MA; Bonatti F; Guidugli L; Aretini P; Galli A Hum Mutat; 2009 Jan; 30(1):123-33. PubMed ID: 18680205 [TBL] [Abstract][Full Text] [Related]
12. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing. Li G; Guo X; Tang L; Chen M; Luo X; Peng L; Xu X; Wang S; Xiao Z; Yi W; Dai L; Wang J J Cancer Res Clin Oncol; 2017 Oct; 143(10):2011-2024. PubMed ID: 28664449 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. Rummel S; Varner E; Shriver CD; Ellsworth RE Breast Cancer Res Treat; 2013 Jan; 137(1):119-25. PubMed ID: 23192404 [TBL] [Abstract][Full Text] [Related]
14. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450 [TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer. Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406 [TBL] [Abstract][Full Text] [Related]
16. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155 [TBL] [Abstract][Full Text] [Related]
17. BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Chen W; Pan K; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lu Y; You W; Xie Y Breast Cancer Res Treat; 2009 Sep; 117(1):55-60. PubMed ID: 18512148 [TBL] [Abstract][Full Text] [Related]
18. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance. Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859 [TBL] [Abstract][Full Text] [Related]
19. The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. Song CG; Hu Z; Wu J; Luo JM; Shen ZZ; Huang W; Shao ZM J Cancer Res Clin Oncol; 2006 Oct; 132(10):617-26. PubMed ID: 16835750 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Rinella ES; Shao Y; Yackowski L; Pramanik S; Oratz R; Schnabel F; Guha S; LeDuc C; Campbell CL; Klugman SD; Terry MB; Senie RT; Andrulis IL; Daly M; John EM; Roses D; Chung WK; Ostrer H Hum Genet; 2013 May; 132(5):523-36. PubMed ID: 23354978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]